| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.097 | 0.008 |